News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Meta is preparing to sell access to its AI compute and models as a cloud product, lifting Meta shares sharply pre-market.
  • CoreWeave and Nebius shares plunged in pre-market trading after reports Meta would market excess AI compute to external customers.
  • President Trump said the U.S. and Iran are 'getting along very well' after Doha talks, suggesting easing Gulf tensions.
  • Goldman Sachs' private credit fund fulfilled repurchase requests equal to about 3.24% of shares, underscoring investor caution in private credit.
  • General Motors signed a strategic agreement with Micron to secure long-term vehicle memory supplies covering LPDRAM, NOR and UFS NAND.
  • Volkswagen unit Cariad and Bosch dissolved their autonomous-driving joint project, ending their formal collaboration.

Latest Articles

Mixed Monday Moves: AMD, Lam Lead Gains While Disney and Tesla Slip

Mixed Monday Moves: AMD, Lam Lead Gains While Disney and Tesla Slip

Stocks across market-cap tiers displayed notable volatility on Monday. Semiconductor names including Advanced Micro Devices and Lam Research outperformed, while several high-profile firms such as Disney and Tesla declined. Movers ranged from mega-cap technology and healthcare names to small-cap companies posting double-digit swings.

Sell the Pop: Shorting Oracle After a $50B Cloud Financing Shock

Sell the Pop: Shorting Oracle After a $50B Cloud Financing Shock

Oracle announced a $45-50 billion funding plan to bulk up Oracle Cloud Infrastructure. That plan flips a typical cloud-growth story into an execution-and-financing event. Given high leverage, negative free cash flow, and a stretched valuation, this is a pragmatic mid-term short (45 trading days) to capture further normalization as investors digest …

Istanbul equities slide as BIST 100 falls 1.57% amid sector-wide weakness

Istanbul equities slide as BIST 100 falls 1.57% amid sector-wide weakness

Turkey's equity benchmark, the BIST 100, closed down 1.57% on Monday as losses in several key sectors pushed the market lower. Advancers were led by Destek Finans Faktoring, Gen Ilac and Batisoke Soke Cimento, while sharp declines at Turk Altin Isletmeleri, Anadolu Metal Madencilik and GurSel Turizm contributed to negative breadth. Commodities and …

Apollo Economist Flags Risk of Rapid Yen Carry Trade Unwind

Apollo Economist Flags Risk of Rapid Yen Carry Trade Unwind

Apollo Management chief economist Torsten Slok warned that the yen carry trade may be vulnerable to a swift reversal after speculative futures positions moved sharply. While futures positioning has become less bearish, Bank for International Settlements data show that yen lending to offshore financial centers and non-bank borrowers remains elevated…

Trump Says Closed Eyes in Cabinet Meeting Were From Boredom, Not Sleep

Trump Says Closed Eyes in Cabinet Meeting Were From Boredom, Not Sleep

President Donald Trump told officials he was not asleep during a December cabinet meeting in which he shut his eyes repeatedly, saying he was simply bored and wanted to leave. The remarks came during an 81-minute televised meeting that the White House shortened from its usual format. The episode underscores ongoing questions about the 79-year-old p…

TD Cowen Keeps Hold on Beta Bionics at $17 After FDA Warning Letter; Financials and Q4 Revenue Provide Cushion

TD Cowen Keeps Hold on Beta Bionics at $17 After FDA Warning Letter; Financials and Q4 Revenue Provide Cushion

TD Cowen has reiterated a Hold rating and a $17.00 price target on Beta Bionics (BBNX) after the company received an FDA Warning Letter. The firm’s initial read suggests the letter does not impose burdensome remediation demands and will not block product sales or 510(k) submissions. Beta Bionics reported preliminary fourth-quarter 2025 revenue of a…

BMO Keeps Neutral Rating on Air Products After Another Strong Quarter

BMO Keeps Neutral Rating on Air Products After Another Strong Quarter

BMO Capital reaffirmed its Market Perform rating on Air Products & Chemicals Inc. (NYSE:APD) and held a $282.00 price target after the company reported a solid quarter that outpaced analyst forecasts. The research note highlighted management's pricing and efficiency controls, clarified balance-sheet exposure for the NEOM project, and assigned CBAM …

BMO Reaffirms Outperform on Canadian National, Sets $158 Price Target as Company Reports Strong Q4 Results

BMO Reaffirms Outperform on Canadian National, Sets $158 Price Target as Company Reports Strong Q4 Results

BMO Capital has reiterated an Outperform rating on Canadian National Railway (CNI) with a $158.00 price target, reflecting confidence in the company’s margin profile and cash generation even as management warns of essentially flat freight volumes in 2026. Fourth-quarter adjusted results topped expectations on productivity gains, but analysts have t…